These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38492032)

  • 1. Ototoxic and nephrotoxic drugs in neonatal intensive care units: results of a Spanish and Italian survey.
    Arribas C; Decembrino N; Raffaeli G; Amodeo I; González-Caballero JL; Riaza M; Ortiz-Movilla R; Massenzi L; Gizzi C; Araimo G; Cattarelli D; Aversa S; Martinelli S; Frezza S; Orfeo L; Mosca F; Cavallaro G; Garrido F;
    Eur J Pediatr; 2024 Jun; 183(6):2625-2636. PubMed ID: 38492032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide use in Italian neonatal intensive care units: a national survey.
    Manfredini VA; Cerini C; Clavenna A; Dotta A; Caccamo ML; Staffler A; Massenzi L; Rezzonico RM;
    Ital J Pediatr; 2020 Jun; 46(1):86. PubMed ID: 32571386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.
    Cuzzolin L; Agostino R
    Eur J Clin Pharmacol; 2016 Jan; 72(1):117-23. PubMed ID: 26490354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit.
    Girardi A; Galletti S; Raschi E; Koci A; Poluzzi E; Faldella G; De Ponti F
    Ital J Pediatr; 2017 Apr; 43(1):37. PubMed ID: 28412957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related nephrotoxic and ototoxic reactions : a link through a predictive mechanistic commonality.
    Verdel BM; van Puijenbroek EP; Souverein PC; Leufkens HG; Egberts AC
    Drug Saf; 2008; 31(10):877-84. PubMed ID: 18759511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxic medication exposure in very low birth weight infants.
    Rhone ET; Carmody JB; Swanson JR; Charlton JR
    J Matern Fetal Neonatal Med; 2014 Sep; 27(14):1485-90. PubMed ID: 24168068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units.
    van der Veen A; Somers A; Vanhaesebrouck S; Ter Heine R; Brüggemann R; Allegaert K; De Cock P
    Int J Clin Pharm; 2022 Apr; 44(2):564-569. PubMed ID: 34727280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic screening of A1555G and C1494T mitochondrial mutations and the use of ototoxic drugs among Jordanians.
    Yehya A; Al-Trad B; Bani-Hmoud M; Rababa'h AM
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5684-5689. PubMed ID: 34604960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
    Robertson CM; Tyebkhan JM; Peliowski A; Etches PC; Cheung PY
    Acta Paediatr; 2006 Feb; 95(2):214-23. PubMed ID: 16449030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced acute kidney injury in neonates.
    Hanna MH; Askenazi DJ; Selewski DT
    Curr Opin Pediatr; 2016 Apr; 28(2):180-7. PubMed ID: 26735892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk indicators for congenital and delayed-onset hearing loss.
    Kraft CT; Malhotra S; Boerst A; Thorne MC
    Otol Neurotol; 2014 Dec; 35(10):1839-43. PubMed ID: 25251299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The care of critically ill infants and toddlers in neonatal intensive care units across Italy and Europe: our proposal for healthcare organization.
    Pozzi N; Cogo P; Moretti C; Biban P; Fedeli T; Orfeo L; Gitto E; Mosca F
    Eur J Pediatr; 2022 Apr; 181(4):1385-1393. PubMed ID: 35088115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute kidney injury in neonatal intensive care: Medicines involved.
    Safina AI; Daminova MA; Abdullina GA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S9-S10. PubMed ID: 26639729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
    Shibeshi W; Sheth AN; Admasu A; Berha AB; Negash Z; Yimer G
    BMC Pharmacol Toxicol; 2019 May; 20(1):31. PubMed ID: 31122273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing loss among high-risk newborns admitted to a tertiary Neonatal Intensive Care Unit.
    Khairy MA; Abuelhamed WA; Ahmed RS; El Fouly HES; Elhawary IM
    J Matern Fetal Neonatal Med; 2018 Jul; 31(13):1756-1761. PubMed ID: 28482715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxicity: etiology and issues.
    D'Alonzo BJ; Cantor AB
    J Fam Pract; 1983 Mar; 16(3):489-94. PubMed ID: 6338150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
    Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
    Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.